低大剂量频率对青少年1型糖尿病自动胰岛素输注系统性能的影响
本研究比较了使用Omnipod 5(OP5)或Tandem Control-IQ(CIQ)的1型糖尿病青少年中,每日大剂量≤3.0次者的TIR差异。经倾向性评分匹配后,CIQ组调整后TIR高8.0%(54.9% vs. 46.9%,P=0.002),且AID使用时间更长(80.0% vs. 64.0%,P=0.01)。
要点
- 低大剂量频率(≤3.0次/天)的青少年AID使用者中,CIQ组TIR显著高于OP5组。
- CIQ组AID使用时间更长(80.0% vs. 64.0%),可能解释TIR差异。
- 两组用户主动大剂量次数无差异(2.2次/天)。
核心结论
- 在每日大剂量≤3.0次的AID使用者中,CIQ使用与更高的TIR相关,可能归因于更长的AID使用时间和AID自动大剂量。
研究设计与样本
- 回顾性队列研究,纳入使用OP5或CIQ且90天内平均每日大剂量≤3.0次的1型糖尿病青少年,采用倾向性评分匹配和多线性回归分析。
主要发现
- 共202例青少年大剂量频率低(CIQ组75/290,OP5组127/535;P=0.5)。
- 倾向性评分匹配98对后,除AID使用时间外组间差异消除,CIQ组AID使用时间更高(80.0% vs. 64.0%;P=0.01)。
- 用户主动大剂量次数无组间差异(2.2次/天)。
- 调整后CIQ组TIR高8.0%(54.9% vs. 46.9%;P=0.002)。
临床怎么用
- 对于大剂量频率低的青少年1型糖尿病患者,选择CIQ可能有助于提高TIR。
- 临床中应关注AID使用时间和自动大剂量对血糖控制的影响。
局限性
- 原文未报告研究设计类型、随访时长及混杂因素控制等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess differences in time in range (TIR) between automated insulin delivery (AID) systems in youth with low bolus frequency. RESEARCH DESIGN AND METHODS: Youth using Omnipod 5 (OP5) or Tandem Control-IQ (CIQ) averaging ≤3.0 boluses/day over 90 days were included. Propensity score matching accounted for between-group differences. A multiple linear regression model assessed for differences in TIR by system. RESULTS: A total of 202 youth had low bolus frequency (n = 75 of 290 using CIQ, n = 127 of 535 using OP5; P = 0.5). Propensity score matching paired 98 youth for analyses and eliminated between-group differences, excluding time in AID, which remained higher for CIQ users (80.0% vs. 64.0%; P = 0.01). There was no between-group difference in user-initiated boluses (2.2 boluses/day). Adjusted TIR was 8.0% higher in CIQ users (54.9% vs. 46.9%; P = 0.002). CONCLUSIONS: Among AID users receiving ≤3.0 boluses/day, CIQ use was associated with greater TIR, likely due to increased time in AID and AID-initiated boluses.
引用
- Chatty P, Gera S, Rearson A, et al. Effect of Low Bolus Frequency on Automated Insulin Delivery System Performance in Youth With Type 1 Diabetes. Diabetes Care. 2026. PMID: 41379540. doi:10.2337/dc25-2082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。